HEADER SIGNALING PROTEIN 19-APR-11 2YGP TITLE WIF DOMAIN-EGF-LIKE DOMAIN 1 MET77TRP OF HUMAN WNT INHIBITORY FACTOR 1 TITLE 2 IN COMPLEX WITH 1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: WNT INHIBITORY FACTOR 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: WIF DOMAIN-EGF-LIKE DOMAIN 1, RESIDUES 35-210; COMPND 5 SYNONYM: WIF-1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: N-ACETYLGLUCOSAMINYLTRANSFERASE I- SOURCE 9 NEGATIVE HEK 293S GNTI(-)CELLS; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_VECTOR: PHLSEC KEYWDS SIGNALING PROTEIN, WNT SIGNALING PATHWAY, WNT ANTAGONIST, MORPHOGEN, KEYWDS 2 CANCER, GLYCOSAMINOGLYCAN EXPDTA X-RAY DIFFRACTION AUTHOR T.MALINAUSKAS,A.R.ARICESCU,W.LU,C.SIEBOLD,E.Y.JONES REVDAT 3 29-JUL-20 2YGP 1 COMPND REMARK HETNAM LINK REVDAT 3 2 1 SITE REVDAT 2 17-AUG-11 2YGP 1 JRNL REVDAT 1 13-JUL-11 2YGP 0 JRNL AUTH T.MALINAUSKAS,A.R.ARICESCU,W.LU,C.SIEBOLD,E.Y.JONES JRNL TITL MODULAR MECHANISM OF WNT SIGNALING INHIBITION BY WNT JRNL TITL 2 INHIBITORY FACTOR 1 JRNL REF NAT.STRUCT.MOL.BIOL. V. 18 886 2011 JRNL REFN ISSN 1545-9993 JRNL PMID 21743455 JRNL DOI 10.1038/NSMB.2081 REMARK 2 REMARK 2 RESOLUTION. 2.22 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.22 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.32 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 10431 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.188 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 502 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.3189 - 3.5256 1.00 2610 121 0.1747 0.2093 REMARK 3 2 3.5256 - 2.7991 1.00 2501 120 0.1687 0.1966 REMARK 3 3 2.7991 - 2.4455 1.00 2455 134 0.2071 0.2949 REMARK 3 4 2.4455 - 2.2220 0.97 2363 127 0.2499 0.2946 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 0.90 REMARK 3 SHRINKAGE RADIUS : 0.61 REMARK 3 K_SOL : 0.37 REMARK 3 B_SOL : 55.78 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.330 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.660 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.19 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 51.04 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 8.80360 REMARK 3 B22 (A**2) : -7.97880 REMARK 3 B33 (A**2) : -0.82480 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.015 1520 REMARK 3 ANGLE : 2.217 2037 REMARK 3 CHIRALITY : 0.149 214 REMARK 3 PLANARITY : 0.009 255 REMARK 3 DIHEDRAL : 19.537 587 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -6.8842 -13.2750 14.9040 REMARK 3 T TENSOR REMARK 3 T11: 0.1811 T22: 0.2028 REMARK 3 T33: 0.1779 T12: -0.0042 REMARK 3 T13: -0.0173 T23: 0.0020 REMARK 3 L TENSOR REMARK 3 L11: 0.7809 L22: 0.4618 REMARK 3 L33: 0.7642 L12: 0.3848 REMARK 3 L13: 0.1523 L23: -0.2585 REMARK 3 S TENSOR REMARK 3 S11: -0.0362 S12: -0.0262 S13: 0.1149 REMARK 3 S21: 0.0060 S22: 0.0385 S23: 0.0930 REMARK 3 S31: -0.1032 S32: -0.0672 S33: -0.0008 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2YGP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-APR-11. REMARK 100 THE DEPOSITION ID IS D_1290048078. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I24 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.978 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10433 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.220 REMARK 200 RESOLUTION RANGE LOW (A) : 29.320 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.22 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.00 REMARK 200 R MERGE FOR SHELL (I) : 0.57000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.1 M DIAMMONIUM TARTRATE, PH 7.0, 20 REMARK 280 MM SPERMIDINE, 0.5 MM CACL2 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z REMARK 290 7555 -X+1/2,Y+1/2,-Z REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 25.38000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 67.12050 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 25.38000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 67.12050 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 25.38000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 67.12050 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 25.38000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 67.12050 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6220 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19210 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -52.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -50.76000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, MET 77 TO TRP REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 32 REMARK 465 LYS A 213 REMARK 465 HIS A 214 REMARK 465 HIS A 215 REMARK 465 HIS A 216 REMARK 465 HIS A 217 REMARK 465 HIS A 218 REMARK 465 HIS A 219 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN A 88 O5 NAG A 1214 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 94 1.24 -63.30 REMARK 500 PRO A 201 -162.11 -76.85 REMARK 500 ASP A 202 109.85 -40.02 REMARK 500 CYS A 209 64.17 62.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2YGQ RELATED DB: PDB REMARK 900 WIF DOMAIN-EPIDERMAL GROWTH FACTOR (EGF)-LIKE DOMAINS 1-3 OF HUMAN REMARK 900 WNT INHIBITORY FACTOR 1 IN COMPLEX WITH 1,2- REMARK 900 DIPALMITOYLPHOSPHATIDYLCHOLINE REMARK 900 RELATED ID: 2YGO RELATED DB: PDB REMARK 900 WIF DOMAIN-EGF-LIKE DOMAIN 1 OF HUMAN WNT INHIBITORY FACTOR 1 IN REMARK 900 COMPLEX WITH 1,2- DIPALMITOYLPHOSPHATIDYLCHOLINE REMARK 900 RELATED ID: 2YGN RELATED DB: PDB REMARK 900 WIF DOMAIN OF HUMAN WNT INHIBITORY FACTOR 1 IN COMPLEX WITH 1,2- REMARK 900 DIPALMITOYLPHOSPHATIDYLCHOLINE REMARK 999 REMARK 999 SEQUENCE REMARK 999 ISOFORM Q166K. THE N-TERMINAL THREE AMINO ACID RESIDUES REMARK 999 (ETG) AND C-TERMINAL NINE AMINO ACID RESIDUES (GTKHHHHHH) REMARK 999 OF THE CRYSTALLISATION CONSTRUCT ARE DERIVED FROM THE REMARK 999 PHLSEC VECTOR, CONTAINS MET77TRP MUTATION. DBREF 2YGP A 35 210 UNP Q9Y5W5 WIF1_HUMAN 35 210 SEQADV 2YGP GLU A 32 UNP Q9Y5W5 EXPRESSION TAG SEQADV 2YGP THR A 33 UNP Q9Y5W5 EXPRESSION TAG SEQADV 2YGP GLY A 34 UNP Q9Y5W5 EXPRESSION TAG SEQADV 2YGP TRP A 77 UNP Q9Y5W5 MET 77 ENGINEERED MUTATION SEQADV 2YGP MLY A 166 UNP Q9Y5W5 GLN 166 VARIANT SEQADV 2YGP GLY A 211 UNP Q9Y5W5 EXPRESSION TAG SEQADV 2YGP THR A 212 UNP Q9Y5W5 EXPRESSION TAG SEQADV 2YGP LYS A 213 UNP Q9Y5W5 EXPRESSION TAG SEQADV 2YGP HIS A 214 UNP Q9Y5W5 EXPRESSION TAG SEQADV 2YGP HIS A 215 UNP Q9Y5W5 EXPRESSION TAG SEQADV 2YGP HIS A 216 UNP Q9Y5W5 EXPRESSION TAG SEQADV 2YGP HIS A 217 UNP Q9Y5W5 EXPRESSION TAG SEQADV 2YGP HIS A 218 UNP Q9Y5W5 EXPRESSION TAG SEQADV 2YGP HIS A 219 UNP Q9Y5W5 EXPRESSION TAG SEQRES 1 A 188 GLU THR GLY SER LEU TYR LEU TRP ILE ASP ALA HIS GLN SEQRES 2 A 188 ALA ARG VAL LEU ILE GLY PHE GLU GLU ASP ILE LEU ILE SEQRES 3 A 188 VAL SER GLU GLY MLY MET ALA PRO PHE THR HIS ASP PHE SEQRES 4 A 188 ARG MLY ALA GLN GLN ARG TRP PRO ALA ILE PRO VAL ASN SEQRES 5 A 188 ILE HIS SER MET ASN PHE THR TRP GLN ALA ALA GLY GLN SEQRES 6 A 188 ALA GLU TYR PHE TYR GLU PHE LEU SER LEU ARG SER LEU SEQRES 7 A 188 ASP MLY GLY ILE MET ALA ASP PRO THR VAL ASN VAL PRO SEQRES 8 A 188 LEU LEU GLY THR VAL PRO HIS MLY ALA SER VAL VAL GLN SEQRES 9 A 188 VAL GLY PHE PRO CYS LEU GLY MLY GLN ASP GLY VAL ALA SEQRES 10 A 188 ALA PHE GLU VAL ASP VAL ILE VAL MET ASN SER GLU GLY SEQRES 11 A 188 ASN THR ILE LEU MLY THR PRO GLN ASN ALA ILE PHE PHE SEQRES 12 A 188 LYS THR CYS GLN GLN ALA GLU CYS PRO GLY GLY CYS ARG SEQRES 13 A 188 ASN GLY GLY PHE CYS ASN GLU ARG ARG ILE CYS GLU CYS SEQRES 14 A 188 PRO ASP GLY PHE HIS GLY PRO HIS CYS GLU GLY THR LYS SEQRES 15 A 188 HIS HIS HIS HIS HIS HIS MODRES 2YGP ASN A 88 ASN GLYCOSYLATION SITE MODRES 2YGP MLY A 62 LYS N-DIMETHYL-LYSINE MODRES 2YGP MLY A 72 LYS N-DIMETHYL-LYSINE MODRES 2YGP MLY A 111 LYS N-DIMETHYL-LYSINE MODRES 2YGP MLY A 130 LYS N-DIMETHYL-LYSINE MODRES 2YGP MLY A 143 LYS N-DIMETHYL-LYSINE MODRES 2YGP MLY A 166 LYS N-DIMETHYL-LYSINE HET MLY A 62 11 HET MLY A 72 11 HET MLY A 111 11 HET MLY A 130 11 HET MLY A 143 11 HET MLY A 166 11 HET PCF A1213 50 HET NAG A1214 14 HET CA A1215 1 HET SPD A1216 10 HETNAM MLY N-DIMETHYL-LYSINE HETNAM PCF 1,2-DIACYL-SN-GLYCERO-3-PHOSHOCHOLINE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM CA CALCIUM ION HETNAM SPD SPERMIDINE HETSYN SPD N-(2-AMINO-PROPYL)-1,4-DIAMINOBUTANE; PA(34) FORMUL 1 MLY 6(C8 H18 N2 O2) FORMUL 2 PCF C40 H80 N O8 P FORMUL 3 NAG C8 H15 N O6 FORMUL 4 CA CA 2+ FORMUL 5 SPD C7 H19 N3 FORMUL 6 HOH *111(H2 O) HELIX 1 1 ASP A 41 GLY A 50 1 10 HELIX 2 2 PRO A 65 HIS A 68 5 4 HELIX 3 3 ASP A 69 GLN A 75 1 7 SHEET 1 AA 6 MLY A 62 MET A 63 0 SHEET 2 AA 6 ILE A 55 SER A 59 -1 O SER A 59 N MLY A 62 SHEET 3 AA 6 LEU A 36 ILE A 40 -1 O LEU A 38 N ILE A 57 SHEET 4 AA 6 SER A 86 ALA A 93 -1 O THR A 90 N TRP A 39 SHEET 5 AA 6 SER A 132 GLY A 137 -1 O SER A 132 N TRP A 91 SHEET 6 AA 6 THR A 118 VAL A 119 -1 O THR A 118 N GLY A 137 SHEET 1 AB 4 LEU A 124 THR A 126 0 SHEET 2 AB 4 TYR A 99 SER A 108 -1 O TYR A 101 N GLY A 125 SHEET 3 AB 4 GLY A 146 ASN A 158 -1 O GLU A 151 N ARG A 107 SHEET 4 AB 4 THR A 163 MLY A 166 -1 N ILE A 164 O VAL A 156 SHEET 1 AC 4 LEU A 124 THR A 126 0 SHEET 2 AC 4 TYR A 99 SER A 108 -1 O TYR A 101 N GLY A 125 SHEET 3 AC 4 GLY A 146 ASN A 158 -1 O GLU A 151 N ARG A 107 SHEET 4 AC 4 PHE A 173 CYS A 177 -1 O PHE A 173 N PHE A 150 SHEET 1 AD 2 THR A 163 MLY A 166 0 SHEET 2 AD 2 GLY A 146 ASN A 158 -1 O VAL A 156 N ILE A 164 SHEET 1 AE 2 PHE A 191 CYS A 192 0 SHEET 2 AE 2 CYS A 198 GLU A 199 -1 O GLU A 199 N PHE A 191 SSBOND 1 CYS A 140 CYS A 177 1555 1555 2.04 SSBOND 2 CYS A 182 CYS A 192 1555 1555 2.03 SSBOND 3 CYS A 186 CYS A 198 1555 1555 2.03 SSBOND 4 CYS A 200 CYS A 209 1555 1555 2.03 LINK C GLY A 61 N MLY A 62 1555 1555 1.33 LINK C MLY A 62 N MET A 63 1555 1555 1.35 LINK C ARG A 71 N MLY A 72 1555 1555 1.34 LINK C MLY A 72 N ALA A 73 1555 1555 1.35 LINK ND2 ASN A 88 C1 NAG A1214 1555 1555 1.43 LINK C ASP A 110 N MLY A 111 1555 1555 1.35 LINK C MLY A 111 N GLY A 112 1555 1555 1.33 LINK C HIS A 129 N MLY A 130 1555 1555 1.33 LINK C MLY A 130 N ALA A 131 1555 1555 1.36 LINK C GLY A 142 N MLY A 143 1555 1555 1.33 LINK C MLY A 143 N GLN A 144 1555 1555 1.38 LINK C LEU A 165 N MLY A 166 1555 1555 1.33 LINK C MLY A 166 N THR A 167 1555 1555 1.34 CRYST1 50.760 134.241 60.193 90.00 90.00 90.00 C 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019701 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007449 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016613 0.00000